None listed
Conditions
Interventions
Intervention1: ropivacaine with nalbuphine: Injection Ropivacaine of 2ml/kg and 10mg of nalbuphine will be given in supraclavicular brachial plexus block under ultrasound guided technique
Control Inte
Sponsors
Pondicherry Institute of medical science
Eligibility
Inclusion criteria
Inclusion criteria: American Society Of Anesthesiologists (ASA) Physical Status I To II Of Both Gender Age Between 18 And 60 Years Body Mass Index (BMI) Elective forearm and hand surgeries in orthopedic and plastic surgeries
Exclusion criteria
Exclusion criteria: Allergy to local anesthetics or Nalbuphine Infection at the injection site Patients with clinically significant coagulopathy Preexisting neuromuscular disorders Severe cardiovascular, or pulmonary disease, renal or hepatic disorder Pregnancy and lactation Patients taking medications with opioid or receiving chronic analgesic therapy other than simple analgesics were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the duration of analgesia between ropivacaine and ropivacaine with nalbuphine for supraclavicular brachial plexus blockadeTimepoint: after complete sensory blockade | — |
Secondary
| Measure | Time frame |
|---|---|
| To measure the onset of sensory and motor blockade and To measure the duration motor blockade between the two study groups To measure the amount of rescue analgesia requirement in the first 24 hours To measure the hemodynamic changes during the procedureTimepoint: after complete sensory and motor blockade till first resue analgesia | — |
Countries
India
Contacts
Public ContactArish
Pondicherry Institute Of Medical Sciences
Outcome results
None listed